Sabra Health Care REIT, Inc. logo SBRA - Sabra Health Care REIT, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 11
HOLD 16
SELL 2
STRONG
SELL
0
| PRICE TARGET: $22.50 DETAILS
HIGH: $25.00
LOW: $21.00
MEDIAN: $22.00
CONSENSUS: $22.50
UPSIDE: 10.35%

Stock News

Sabra Reports Second Quarter 2026 Results; Reiterates 2026 Guidance

Sabra Reports Second Quarter 2026 Results; Reiterates 2026 Guidance

TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #2Q26--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the second quarter of 2026. SECOND QUARTER 2026 RESULTS AND RECENT EVENTS Results per diluted common share for the second quarter of 2026 were as follows: Net Loss: $(0.10) FFO: $(0.02) Normalized FFO: $0.38 AFFO: $0.39 Normalized AFFO: $0.40 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.49x Senior Housing - Leased: 1.52x B.

Aug 03, 2026 12:05 PM businesswire.com
Sabra Health Care REIT, Inc., Publishes Sixth Annual Sustainability Report

Sabra Health Care REIT, Inc., Publishes Sixth Annual Sustainability Report

TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #ESG--Sabra Health Care REIT, Inc. (“Sabra” or the “Company”) (Nasdaq: SBRA) today released its sixth annual Sustainability Report for fiscal year 2025.The report highlights how Sabra is scaling successful pilot technologies into portfolio-wide initiatives, expanding solutions that improve care delivery and continuing to invest in resilient, efficient operations. Together with the Company's broader sustainability efforts, these initiatives reflect Sabra's continued int.

Jul 23, 2026 05:05 AM businesswire.com
Sabra Issues Business Update and Increases Full-Year 2026 Guidance

Sabra Issues Business Update and Increases Full-Year 2026 Guidance

TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #GUIDANCE--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced a business update detailed below. Portfolio Update Sabra has entered into letters of intent to re-tenant all of its 26 properties leased to Avamere (“Avamere”). Under the proposed transition, 22 properties would be transitioned to subsidiaries of Cascadia Healthcare (“Cascadia”), a leading diversified healthcare operator concentrated in the Pacific Northwest with approxi.

Jul 21, 2026 05:05 AM businesswire.com
Sabra Health Care REIT, Inc. Announces Second Quarter 2026 Earnings Release Date and Conference Call

Sabra Health Care REIT, Inc. Announces Second Quarter 2026 Earnings Release Date and Conference Call

TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #2Q26--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2026 second quarter earnings release on August 3, 2026, after the close of trading.A conference call with a simultaneous webcast to discuss the 2026 second quarter results will be held on Tuesday, August 4th at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID n.

Jul 20, 2026 12:05 PM businesswire.com
Sabra Health Care: Pivoting To Win From An Unstoppable Demographic Tailwind

Sabra Health Care: Pivoting To Win From An Unstoppable Demographic Tailwind

Sabra Health Care REIT remains a Buy, driven by its aggressive pivot into the Seniors Housing Operating Portfolio model. SBRA's SHOP transition offers direct exposure to demographic tailwinds from the 'Silver Tsunami,' positioning for significant potential occupancy and AFFO growth. Q1 results were strong, with AFFO at $0.39/share, nearly reaching the annual investment target, and a 77% dividend payout ratio supporting a ~6% yield.

Jul 09, 2026 01:44 PM seekingalpha.com

Price Targets